Evogene Ltd.
$0.48
The Read: 9% drop after Q1 2026 results due to cash runway concerns, but can rally about 27% on strategic funding news, showing moves around 15–30% on key catalysts.
EVGN
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$0.48
The Read: 9% drop after Q1 2026 results due to cash runway concerns, but can rally about 27% on strategic funding news, showing moves around 15–30% on key catalysts.
No Data